However, it is clear that GAS5 can participate in the progression of cancer by targeting microRNA17–19, and mir-217 is also one of the target genes of GAS520, which provides a theoretical basis for GAS5 to the regulation of myocardial fibrosis through mir-217/sirt1 pathway. Here, GAS5 is linked to cancer.